Fairmount Healthcare Fund II L.P.'s Net Worth
$0
Estimate Recalculated Nov 11, 2024 08:52AM EST
Who is Fairmount Healthcare Fund II L.P.?
Fairmount Healthcare Fund II L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Apogee Therapeutics, Inc., Viridian Therapeutics, Inc.\DE, Spyre Therapeutics, Inc., and Oruka Therapeutics, Inc..
SEC CIK
Fairmount Healthcare Fund II L.P.'s CIK is 0001769651
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Apogee Therapeutics, Inc. (APGE) Snapshot price: $47.25
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
| 2.05M |
Mar 28
| |||
Form 4
| -88.53% | -790.20K |
—
|
—
| 102.33K |
Scheduled
|
Jan 29
| ||
Form 4
|
∞
| 2.94M |
$17.00 | $49,999,992.00 | 2.94M |
Jul 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Spyre Therapeutics, Inc. (AGLE) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +961.81% | 3.64M |
—
|
—
| 4.02M |
Apr 25
| |||
Form 4
| -76.36% | -2.62M |
—
|
—
| 812.08K |
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
|
∞
| 3.44M |
—
|
—
| 3.44M |
Nov 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oruka Therapeutics, Inc. (ORKA) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +75.63% | 275K |
$23.00 | $6,325,000.00 | 638.61K |
Sep 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zenas BioPharma, Inc. (ZBIO) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +557.42% | 1.6M |
$17.00 |
—
| 1.89M |
Sep 12 - Sep 16
| |||
Form 4
| +3,901.05% | 1.6M |
$17.00 |
—
| 1.65M |
Sep 12 - Sep 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Viridian Therapeutics, Inc.\DE (VRDN) Snapshot price: $14.09
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +86.68% | 1.6M |
$18.75 | $30,000,000.00 | 3.45M |
Sep 13
| |||
Form 4
|
—
|
0
|
—
|
—
| 1.85M |
Mar 28
| |||
Form 4
| +34.92% | 476.19K |
$21.00 | $9,999,990.00 | 1.84M |
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 4
| +45.35% | 425.53K |
$23.50 | $9,999,978.50 | 1.36M |
Aug 17
| |||
Form 4
| +3,109.50% | 909K |
$11.00 | $9,999,000.00 | 938.23K |
Sep 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 526.39K |
—
|
—
| 526.39K |
Oct 27
| |||
| No matching records found | |||||||||